WATSON PHARMACEUTICALS, INC.;TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
申请号:
EP06738170.7
公开号:
EP1863445B1
申请日:
2006.03.13
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.